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Influence of twenty-five per cent human serum albumin on total
and ionized calcium concentrations in vivo
Brian L Erstad, Hal Richards, Susan Rose, Paul Nakazato and John Fortune
Background: A inverse correlation has been found between changes in ionized
calcium concentrations and the addition of albumin in vitro, which may explain
adverse cardiovascular effects attributed to exogenous albumin in vivo. The
purpose of this investigation was to determine the interaction (if any) between
exogenous 25% albumin administration (100ml given over <30min) and calcium
concentrations in patients, all but one of whom were in an intensive care unit.
Results: There were no significant differences in the ionized calcium
concentrations obtained before, at the end and 6h after the administration of
albumin (1.09±0.23, 1.06±0.22, 1.06±0.21mmol/l, respectively). Similarly,
there were no significant differences in the total calcium concentrations between
these same time periods (2.03±0.18, 2.05±0.20, 2.08±0.23 mmol/l,
respectively).
Conclusions: In patients receiving infusions of 25% albumin, it appears that
circulating calcium concentrations are well regulated by homeostatic
mechanisms. Albumin infusions had no effect on calcium concentrations,
although it is possible that temporary changes of questionable clinical
importance may have occurred between measurement periods.
Address:  Arizona Health Sciences Center,
Departments of Pharmacy Practice & Science and
Surgery, Tucson, Arizona, USA
Sponsorship:  Funding provided by the American
Red Cross.
Correspondence:  Brian L Erstad, Pharm D,
FCCM, Associate Professor, College of Pharmacy,
University of Arizona, PO Box 210207, Tucson, AZ
85721-0207, USA, Tel: 520 694 5600;
fax 520 626 4063;
e-mail: erstad@pharmacy.arizona.edu
Keywords: albumin, albumin administration,
calcium concentrations, adverse effects
Received: 21 June 1999
Revisions requested: 6 July 1999
Revisions received: 15 July 1999
Accepted: 19 July 1999
Published: 4 August 1999
Crit Care 1999, 3:117–121
The original version of this paper is the electronic
version which can be seen on the Internet
(http://ccforum.com). The electronic version may
contain additional information to that appearing in
the paper version.
© Current Science Ltd ISSN 1364-8535
Research paper 117
Introduction
Three forms of calcium circulate in the blood: protein
bound (primarily albumin), chelated and ionized. Ionized
calcium constitutes 40–50% of total calcium [1,2]. This frac-
tion is the physiologically active form of calcium, which is
regulated by homeostasis [3]. Total calcium concentrations
measure all three forms and thus may not accurately indi-
cate the amount of ionized calcium in the blood. Changes in
protein binding may affect the concentration of unbound,
ionized calcium and binding affinity, which is not pre-
dictable from one individual to another [4]. Furthermore,
binding can be altered in circumstances such as acid–base
imbalance and pancreatitis [2]. Theoretically, the addition
of exogenous albumin to the bloodstream would increase
the number of binding sites for calcium, which could result
in a lower ionized calcium concentration. Total calcium con-
centrations would not be expected to change as a result of
this increased binding by albumin, assuming there were no
concomitant changes in calcium distribution or elimination.
In a previous study [5] increasing amounts of albumin
were added to human sera obtained from placental and
cord venous samples in order to detect possible changes in
ionized calcium concentrations. Twenty-five per cent
albumin was added to each serum sample to achieve
incremental concentrations from 0 to 2.0g/dl. A significant
decrease in serum ionized calcium concentrations upon
increasing the albumin concentration from 1.0 to 2.0g/dl
was observed. The authors postulated that a decrease in
serum ionized calcium concentration in vivo might be cor-
rected by compensatory mechanisms involving parathy-
roid hormone, calcitriol, and calcitonin. How quickly and
to what degree this compensation is effective has not yet
been elucidated.
In addition to the in-vitro data, studies involving injured
patients [6,7] have found decreases in calcium concentra-
tions that appeared to be associated with albumin admin-
istration. The lower ionized calcium concentrations
observed in patients receiving supplemental albumin
were associated with decreases in left ventricular stroke
work index. It was suggested that this decrease in stroke
work index might have been at least partly responsible for
some of the patients’ heart failure and pulmonary edema.It is well established that hypocalcemia is relatively
common in critically ill patients, although the incidence
has ranged from 12 to 70% in published studies [2,8,9].
Furthermore, albumin infusions are frequently given in
the critical care setting as a volume expander [10,11].
Therefore, fluctuations in ionized calcium concentrations
due to exogenous albumin administration could place
these patients at risk for symptomatic hypocalcemia.
Although clinical features of hypocalcemia are often non-
specific and may go undetected in milder forms, signs and
symptoms of deficiency may include tetany, muscle weak-
ness, parasthesias, adverse cardiovascular effects, bron-
chospasm, and confusion. 
Despite the postulated interaction between albumin and
calcium mentioned in published literature, a retrospective
analysis of several patients in our intensive care unit did
not reveal any changes in ionized calcium concentrations
after 25% albumin infusions. This retrospective data col-
lection was possible in some of our pre- and post-liver
transplant patients who were having multiple arterial
blood gas samples (with assessment of ionized calcium
concentrations) drawn while receiving 25% albumin.
Given the discrepancies noted between the published lit-
erature and patients at our institution, a prospective inves-
tigation was conducted to determine whether albumin
infusions decreased ionized calcium concentrations in
vivo. Because high concentrations of albumin infused as a
bolus are more likely to result in a precipitous drop in
ionized calcium concentrations, this study only included
patients receiving infusions of 25% albumin 100ml (25g),
over a period of less than 30min.
Methods and materials
This prospective study was conducted at University
Medical Center, a 360-bed tertiary care center located in
Southern Arizona. Only English speaking patients who
were at least 18 years of age and who received 100ml 25%
albumin (Baxter Healthcare Corporation, Glendale, Cali-
fornia, USA) over a period less than 30min were eligible
for enrolment. Because parathyroid disease can cause
ionized hypocalcemia, such patients were excluded. Also
excluded were patients with acute renal failure, pancreati-
tis, and marked acid–base imbalances (pH <7.35 or
>7.45), because these conditions have been associated
with protein-calcium binding abnormalities that could
affect ionized calcium concentrations. Finally, patients
receiving medications that could cause acute changes in
calcium or albumin concentrations (eg calcium or phos-
phate supplements, diuretics, or albumin-containing prod-
ucts) were excluded. Consent was obtained and each
patient underwent a protocol previously approved by the
institution’s Human Subjects Committee.
All patients had indwelling arterial and venous
catheters, so potential alterations in calcium concentra-
tions related to the use of tourniquets were not an issue
[9]. Because our laboratory performed automated blood
chemistry studies, there were recordings for 18 measure-
ments (eg blood urea nitrogen, creatinine, phosphorus,
magnesium) in addition to the albumin and total calcium
concentrations under direct investigation. From each
individual we obtained arterial blood samples at the fol-
lowing three times: within 1h before albumin infusion
(baseline), after the end of albumin infusion, and 6h
after albumin infusion. At each time, we determined
albumin, total calcium, and ionized calcium concentra-
tions. One sample was collected for determination of
albumin and total calcium concentrations measured
using CX7 (Beckman, LaBrea, California, USA) in our
main laboratory. Another sample was collected for deter-
mination of the ionized calcium concentration adjusted
for pH of 7.4 and measured by ion-selective electrode
Synthesis 25 (Instrumentation Laboratory, Lexington,
Massachusetts) located in our blood gas laboratory. This
institution’s standard units and normal adult ranges are
as follows: total calcium 2.13–2.65mmol/l and albumin
3.7–5.0g/dl. The normal range for ionized calcium at pH
7.4 is 1.12–1.23mmol/l for adults. A sampling of 25%
albumin was analyzed to determine whether the product
itself might contain calcium. Calcium was undetectable
in the commercially available 25% albumin product
(testing methods were unable to detect concentrations
<2mg/dl).
Information regarding each patient was collected, includ-
ing age, sex, diagnoses and concomitant disease states, and
concurrent medications. Patients were observed and
charts were reviewed for evidence of adverse reactions
during and shortly after the albumin infusion. 
Statistical analysis
The differences in the ionized calcium, total calcium, and
albumin concentrations before, at the end of, and 6h after
the albumin infusion were analyzed using repeated mea-
sures analysis of variance with significance defined as
P<0.05. Data are expressed as means±standard deviation,
unless otherwise noted.
Results
Nine patients were enroled in the prospective study. All
of these patients were receiving the albumin infusions to
maintain intravascular volume in the presence of third-
spaced fluid accumulation. The albumin was typically
infused over 15–20min (<30min was required for study
enrolment). It was presumed that a substantial portion of
the intravascular expansion would result from fluid shift-
ing caused by the oncotic actions of the 25% albumin solu-
tion. Table 1 contains the patient demographics and the
patients’ primary problems. The majority of enroled
patients received the albumin infusions within 5days of
major surgery. 
118 Critical Care 1999, Vol 3 No 4There were no significant differences in either the ionized
or total calcium concentrations obtained before and after
the administration of albumin (Figs 1 and 2). There was
no obvious pattern to the changes that did occur in
calcium concentrations. The largest decrease in ionized
calcium concentrations that occurred in any of the patients
was 0.23mmol/l (1.06mmol/l before and 0.83mmol/l at the
end of albumin infusion). The 6-h ionized calcium con-
centration in this patient was 0.96mmol/l. In contrast,
another patient had a baseline ionized calcium concentra-
tion of 0.91mmol/l, which then increased to 0.93 and
0.99mmol/l at the end of albumin infusion and 6h after,
respectively.
There were no changes detected in other parameters that
might have influenced calcium concentrations. For
example, there were no substantial changes in other labo-
ratory variables such as phosphorus and magnesium.
Although all but one of the patients was in the intensive
care unit during the study, there were no acute events
during the 6-h monitoring period that could potentially
have interfered with the calcium measurements. 
As expected, the mean albumin concentration did increase
from the baseline measurement to the end of and 6h after
administration of the 25% albumin solution (Fig. 3),
although the increase was not statistically significant.
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Figure 1
Ionized calcium concentrations before and after albumin infusions.
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Figure 2
Total calcium concentrations before and after albumin infusions.
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Table 1
Demographics and primary problems of patients in prospective
study
Age
Pt (years) Sex Primary problem
1 62 Male Complications of end-stage liver 
disease secondary to cirrhosis
2 56 Female Intestinal complications secondary to 
disseminated malignancy
3 84 Male Multiple trauma
4 37 Female Post-liver transplant secondary to 
hepatitis C
5 27 Female Post-liver transplant secondary to 
autoimmune hepatitis
6 40 Male Complications of end-stage liver 
disease secondary to hepatitis C
7 57 Male Multiple trauma and burns from motor 
vehicle accident
8 39 Male Post-liver transplant secondary to 
alcoholic cirrhosis
9 62 Female Perforated diverticulum with bowel 
resection and colostomy
Pt, patient.
Figure 3
Albumin concentrations before and after albumin infusions.
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Although the appropriate indications for albumin are con-
troversial, substantial amounts continue to be used, often
inappropriately [10]. Using published guidelines, an
observational study involving 15 academic medical centers
[11] found that 62% of prescriptions for albumin were
inappropriate, with an associated cost of US$124939. In
addition to efficacy and cost, adverse effects should be
considered when discussing therapeutic options.
The primary adverse effects associated with the use of
albumin have been extensions of its pharmacologic actions
(eg fluid overload resulting in pulmonary edema) [12].
Most of the remaining adverse effects attributed to
albumin can be classified by either the involved system
(immunologic, coagulation, renal, hepatic, respiratory,
cardiovascular) or specific type of problem (metal 
loading, amino acid alterations). With regard to possible
cardiovascular adverse effects, research conducted in the
late 1970s and early 1980s on 94 injured patients [6,7] sug-
gested a possible relationship between exogenous
albumin administration and negative inotropic effects that
were possibly related to alterations in calcium homeosta-
sis. The patients were admitted to an emergency surgery
service and were subsequently randomized to receive
resuscitation regimens with or without supplemental
albumin. The patients randomly allocated to receive sup-
plemental albumin had higher total calcium concentra-
tions (2.15±0.30mmol/l versus 2.03±0.18mmol/l;
P<0.025) and lower ionized calcium concentrations
(0.91±0.20mmol/l versus 0.98±0.10mmol/l; P<0.025) in
the immediate postoperative period. The changes in
ionized and total calcium concentrations were moderately
correlated (r=0.4) to changes in left ventricular stroke
work index, and the investigators felt that this negative
inotropic effect was at least partly responsible for the heart
failure and pulmonary edema seen in some of the patients
who were supplemented with albumin. Concerns arise as
to comparability of the groups in such critically ill patients,
however, given possible differences in the resuscitation
regimens (eg administration of fresh frozen plasma that
contains albumin and citrate, intravenous calcium injec-
tions). Also, the homeostatic changes relative to plasma
albumin and calcium are complex as demonstrated by
decreases in ionized and total calcium concentrations in
hypoalbuminemic patients who have undergone car-
diopulmonary bypass surgery [13].
Some of the best in-vitro data that support an effect of
albumin on ionized calcium concentrations [5] involved
the sequential addition of human serum albumin to pla-
cental and cord serum samples taken from healthy
neonates. As concentrations of albumin added to the
serum samples were increased, the ionized calcium con-
centrations decreased. This negative correlation between
the changes in concentrations was significant (P<0.001,
r2=0.76) when univariate and multivariate analyses were
used. The only other significant changes using multivari-
ate analysis were a negative correlation noted between the
change in ionized calcium concentrations compared with
baseline ionized calcium concentrations, and a positive
correlation noted between the change in ionized calcium
concentrations and baseline albumin concentrations. As
mentioned by the authors of that study [5], the most
important question not answered by this investigation was
whether normal in-vivo compensatory mechanisms (ie
stimulation of parathyroid hormone secretion, increased
production of vitamin D precursors, decreased calcitonin
production) would offset the changes induced by albumin.
Our study was unable to find any effects of 25% albumin
on either total or ionized calcium concentrations in
patients, all but one of whom were in the intensive care
unit. It is possible that larger doses of albumin may have
an effect on ionized calcium concentrations, although the
lack of substantial changes at these concentrations in the
present study argues against this. Another study limitation
was the relatively small number of enrolled patients and
their associated illnesses. It is possible that significant
changes in ionized calcium concentrations would be found
if more patients were studied, but again the minor fluctua-
tions in concentrations noted in this investigation seem to
make this unlikely. We did not exclude patients on the
basis of disease states that might affect calcium concentra-
tions, unless the disease state directly affected the body’s
ability to compensate for hypocalcemia as might occur in
patients with parathyroid or renal dysfunction. Despite
differing primary diagnoses and secondary problems such
as infection that commonly occur in intensive care unit
patients, both the total and ionized calcium concentrations
were remarkably stable over the measurement period.
One limitation of our study concerns the number of
assessment points and the rate of albumin infusion. It was
presumed that any effect on ionized calcium would be
maximal at the end of the albumin infusion. The ionized
calcium concentration was assessed at 6h after albumin
infusion to determine whether the concentration was
increasing towards normality if a substantial decrease had
been found. It is possible, however, that decreases in the
ionized calcium concentrations may have occurred during
the albumin infusion or between the postinfusion mea-
surement periods. The time period over which the
albumin infusions were administered for study inclusion
(ie 100ml given over <30min) was based on typical infu-
sion rates observed at the study hospital. This rate of infu-
sion is faster than the 1ml/min rate commonly
recommended in medication handbooks for 25% albumin
[14]. It is possible that 100 ml infusions of 25% solution
given very rapidly (eg <5min) might cause clinically
important decreases in ionized calcium concentrations.
Furthermore, if a more intensive blood sampling strategy
120 Critical Care 1999, Vol 3 No 4had been used in this investigation, it is possible that sub-
stantial decreases in ionized calcium concentrations may
have been observed. These hypotheses require further
investigation. With regard to this study, it is suspected
that transient decreases in the ionized calcium concentra-
tions found with more intensive blood sampling would be
of questionable clinical importance.
A critically low value for ionized calcium concentrations
has been proposed on the basis of an investigation con-
ducted in patients undergoing hepatic transplantation and
a review of the literature [15], but the duration of the
decrease needed to elicit overt problems is less clear. The
authors suggested that the value should not be allowed to
fall acutely to more than 0.4mmol/l below the reference
range mean in order to prevent a variety of adverse effects
such as tetany, hypotension, and arrhythmias. Studies
investigating mortality associated with hypocalcemia [4,9]
have had disparate results.
In conclusion, this investigation did not find a significant
interaction between 25% albumin administration and
calcium concentrations. It is possible that significant
decreases in ionized calcium concentrations could occur in
populations not studied, and that these decreases could be
clinically important in patients predisposed to suboptimal
compensatory responses (eg in neonates). Such popula-
tions require further study. In adult patients, intensive
monitoring of calcium concentrations does not appear war-
ranted during administration of human serum albumin in
doses of 25g or less.
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